Versant Capital Management’s Guardant Health GH Stock Holding History

Versant Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3K	Sell	75 -22	-23%	-$2.39K	﹤0.01%	2194
2026 Q1	$8.96K	Buy	97 +36	+59%	+$3.61K	﹤0.01%	2184
2025 Q4	$6.23K	Hold	61	–	–	﹤0.01%	2173
2025 Q3	$3.81K	Hold	61	–	–	﹤0.01%	2303
2025 Q2	$3.17K	Sell	61 -7	-10%	-$313	﹤0.01%	2291
2025 Q1	$2.9K	Buy	68 +7	+11%	+$302	﹤0.01%	2211
2024 Q4	$1.86K	Buy	+61	New	+$1.72K	﹤0.01%	2072
2024 Q1	–	Sell	-21	Closed	-$568	–	1907
2023 Q4	$568	Hold	21	–	–	﹤0.01%	1648
2023 Q3	$622	Hold	21	–	–	﹤0.01%	1656
2023 Q2	$752	Buy	+21	New	+$603	﹤0.01%	1702

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Versant Capital Management's GH Position: Q2 2026 in Review

Versant Capital Management reduced its Guardant Health (GH) stake by 23% in Q2 2026, selling an estimated $2.39K and leaving 75 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Versant Capital Management first reported a position in GH in Q2 2023 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Versant Capital Management held 75 shares of Guardant Health worth $11.3K as of Q2 2026.
Versant Capital Management sold 22 Guardant Health shares in Q2 2026, an estimated $2.39K.
Guardant Health made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2194 holding.
Versant Capital Management first reported a position in Guardant Health in Q2 2023 and has held it in 10 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.